DDL logo
Menu
  • The Aerosol Society logo
DDL logo
  • DDL2021
    • New Researcher Network
    • Media Partners
  • Archive
    • Conference Papers Archive
    • DDL2020
      • Conference Papers
      • Speakers
      • Sponsors
    • DDL2019
      • Conference Papers
      • Speakers
      • Sponsors
    • DDL2018
      • Conference Papers
      • Speakers
      • Sponsors
    • DDL2017
      • Conference Papers
      • Speakers
      • Sponsors
    • DDL2016
      • Conference Papers
      • Speakers
      • Sponsors
    • DDL2015
      • Conference Papers
    • Previous Years
  • DDL Annual Lecture
  • Awards & Grants
    • DDL Career Development Grant
    • The DDL Emerging Scientist Award
    • The Pat Burnell Young Investigator Award
  • About
    • History
    • DDL Charter
    • Committee
    • Scientific Advisors
  • External Events
    • 2021 ISAM Congress
    • RDD 2021
  • Contact
  • The Aerosol Society logo
loading...

Dr. Tony Hickey :

Dr. Tony Hickey

Research Triangle Institute & Eshelman School of Pharmacy

Paper: Why we need to deliver large amounts of powder to the lungs and the concurrent challenges

Download Paper Download Presentation PDF

Dr. Hickey is Distinguished RTI Fellow, at the Research Triangle Institute and Director of the UNC Catalyst for Rare Diseases of the Eshelman School of Pharmacy He obtained Ph.D. and D.Sc. degrees in pharmaceutical sciences from Aston University, Birmingham, UK. He is a Fellow of the Royal Society of Biology, the American Association of Pharmaceutical Scientists, the American Association for the Advancement of Science and the Royal Society of Biology. He received the Research Achievement Award of the Particulate Presentations and Design Division of the Powder Technology Society of Japan, the Distinguished Scientist Award of the American Association of Indian Pharmaceutical Scientists; the David W Grant Award in Physical Pharmacy of the American Association of Pharmaceutical Scientists; Thomas T Mercer Joint Prize for Excellence in Inhaled Medicines and Pharmaceutical Aerosols of the American Association for Aerosol Research and the International Society for Aerosols in Medicine and the Ralph Shangraw Memorial Award for Excipient and Excipient Technology of the International Pharmaceutical Excipient Consortium Foundation. He is founder (and formerly President and CEO) of Cirrus Pharmaceuticals, Inc., acquired by Kemwell Pharma; founder (formerly CSO, 2002-2007) of Oriel Therapeutics, Inc, acquired by Sandoz and founder and CEO of Astartein, Inc.; member of the Pharmaceutical Dosage Forms Expert Committee of the United States Pharmacopeia and formerly Chair of the Aerosols Expert Committee of the USP. Dr. Hickey conducts a multidisciplinary research program in the field of pulmonary drug and vaccine delivery for treatment and prevention of a variety of diseases.

Photos of Dr. Tony Hickey

Video of Dr. Tony Hickey

  • Terms
  • Privacy & Cookie policy
  • Contact
  • Committee

© 2021 Drug Delivery to the Lungs Website design: definingdesign.co.uk